報價延遲最少15分鐘:2026/11/04 14:31 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.8607 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-5.37/-3.00
|
|
企業價值
13.98M
|
| 資產負債 |
|
每股賬面淨值
1.10
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
2.77M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Radiopharm Theranostics Ltd is a clinical-stage radiotherapeutics company focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. It develops and commercializes radiopharmaceutical platforms for therapeutic and diagnostic applications in precision oncology. The Company develops targeted and scientifically validated radiopharmaceutical technologies in pre-clinical and clinical stages. It has one reportable segment, being the research, development, and commercialization of health technologies. The Company operates in Australia and the United States, with maximum revenue from the United States. |
